Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Dec;85(12):1426-8.
doi: 10.1136/bjo.85.12.1426.

Plasma malondialdehyde and nitric oxide levels in age related macular degeneration

Affiliations

Plasma malondialdehyde and nitric oxide levels in age related macular degeneration

Y Totan et al. Br J Ophthalmol. 2001 Dec.

Abstract

Aims: To evaluate alteration of plasma malondialdehyde (MDA) and nitric oxide (NO) levels in patients with exudative age related macular degeneration (ARMD).

Methods: Plasma nitrite plus nitrate concentrations as an index of plasma NO levels and plasma MDA level as a marker of lipid peroxidation were measured in patients with exudative ARMD and age and sex matched healthy subjects.

Results: Significantly higher MDA and lower NO levels were detected in plasma of patients with ARMD compared with their controls (p=0.01, p=0.001, respectively).

Conclusion: The results may support involvement of oxidative damage and vascular theory in the pathogenesis of ARMD as part of the ageing process.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Plot of plasma malondialdehyde (MDA) levels in patients with age related macular degeneration (ARMD) and control subjects.
Figure 2
Figure 2
Plot of plasma nitrite plus nitrate levels in patients with age related macular degeneration (ARMD) and control subjects.

Similar articles

Cited by

References

    1. Prog Retin Eye Res. 2000 Mar;19(2):205-21 - PubMed
    1. Diabetes Metab Res Rev. 1999 Jul-Aug;15(4):283-8 - PubMed
    1. Prog Lipid Res. 1983;22(2):79-131 - PubMed
    1. Clin Chem. 1990 Aug;36(8 Pt 1):1440-3 - PubMed
    1. Invest Ophthalmol Vis Sci. 1992 Dec;33(13):3497-9 - PubMed